Fill out the form below to watch the webinar

In this webinar, presenters highlight innovative solutions to support AAV production workflows. Originally presented at the ASGCT 2021 virtual annual meeting.

Topics covered:

• Scalable, high-titer, simplified AAV production using the AAV-MAX helper free AAV Production System
• Benefits of using a media panel to address the diversity of HEK293 cell lines
• The current CGT regulatory landscape:
  • Paradigm shift towards cell and gene therapies as curative treatment
  • Regulatory pathways for accelerated approval
  • Virtual inspections and business continuity

(*Indicates a mandatory field)

First name*

Last name*

Telephone*

Email*

Job Role*

Please selectCEO / COO / PresidentCore Facility/Service ProviderDepartment HeadDirectorFaculty / EducatorLab ManagerManagerPhysician / Medical DoctorPostdoctoral FellowPrincipal InvestigatorProject / Program ManagerPurchaser / ProcurerResearch Assistant / Lab TechnicianScientist / Associate ScientistStudent / Graduate StudentVice PresidentOther

Institution*

City*

Country/Region*

Please selectAfghanistanAland IslandsAlbaniaAlgeriaAmerican SamoaAndorraAngolaAnguillaAntarcticaAntigua and BarbudaArgentinaArmeniaArubaAustraliaAustriaAzerbaijanBahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBermudaBhutanBoliviaBonaireBosnia & HerzegovinaBotswanaBouvet IslandBrasilBritish Indian OceanBritish Virgin IslandsBruneiBulgariaBurkina FasoBurundiCambodiaCameroonCanadaCape VerdeCayman IslandsCentral African RepublicChadChileChinaChristmas IslandCocos IslandsColombiaComorosCongoCook IslandsCosta RicaCôte D'IvoireCroatiaCuracaoCyprusCzech RepublicDemocratic Republic of CongoDenmarkDjiboutiDominicaDominican RepublicTIMOR-LESTEEcuadorEgyptEl SalvadorEquatorial GuineaEritreaEstoniaEthiopiaFalkland IslandsFaroe IslandsFederated States of MicronesiaFijiFinlandFranceFrench GuianaFrench PolynesiaFrench Southern TerritoriesGabonGambiaGeorgiaGermanyGhanaGibraltarGreeceGreenlandGrenadaGuadeloupeGuamGuatemalaGuernseyGuianaGuineaGuinea - BissauHaitiHeard Island and McDonald IslandsHondurasHong KongHungaryIcelandIndiaIndonesiaIraqIrelandIsraelItalyJamaicaJapanJerseyJordanKazakhstanKenyaKiribatiKuwaitKyrgyzstanLaosLatviaLebanonLesothoLiberiaLibyaLiechtensteinLithuaniaLuxembourgMacauMacedoniaMadagascarMalawiMalaysiaMaldivesMaliMaltaMarshall IslandsMartiniqueMauritaniaMauritiusMayotteMexicoMoldovaMonacoMongoliaMontenegroMontserratMoroccoMozambiqueMyanmarNamibiaNauruNepalNetherlandsNew CaledoniaNew ZealandNicaraguaNigerNigeriaNiueNorfolk IslandNorwayOmanPakistanPalauPalestinePanamaPapua New GuineaParaguayPeruPhilippinesPitcairn IslandsPolandPortugalPuerto RicoQatarRéunionRomaniaRussiaRwandaSaint HelenaSaint Kitts and NevisSaint LuciaSaint Pierre and MiquelonSaint Vincent and the GrenadinesSan MarinoSão Tomé and PríncipeSaudi ArabiaSenegalSerbiaSeychellesSierra LeoneSingaporeSaint MaartenSlovakiaSloveniaSolomon IslandsSomaliaSamoaSouth AfricaSouth Georgia and the South Sandwich IslandsSouth KoreaSouth SudanSpainSri LankaSudanSurinameSvalbard and Jan MayenSwazilandSwedenSwitzerlandSyriaTaiwanTajikistanTanzaniaThailandTogoTokelauTongaTrinidad and TobagoTunisiaTurkeyTurkmenistanTurks and Caicos IslandsTuvaluUgandaUnited KingdomUkraineUnited Arab EmiratesUnited StatesUnited States Minor Outlying IslandsUruguayUzbekistanVanuatuVatican CityVenezuelaViet NamVirgin IslandsWallis and FutunaWestern SaharaYemenZambiaZimbabwe

What gene modification modality are you working with? Check all that apply*

Adeno-associated Virus (AAV)

Lentivirus (LV)

Non-viral- delivery

Other

Would you like to schedule a product demo or request pricing information?*

Yes

No

What is your purchase timeline?*

0-6 months

7-12 months

12 months or more

Not planning on making a purchase

Submit